Major shareholder announcement - Pharma Equity Group A/S

Udgivet den 23-04-2024  |  kl. 09:45  |  
   
   
  Major shareholder announcement - Pharma Equity Group A/S
   

23 April 2024
Company Announcement no. 14

 

Pharma Equity Group A/S has, in accordance with section 38 of the Capital Markets Act, received major shareholder notification, that DMZ Holding ApS has acquired shares in Pharma Equity Group A/S.

 

As a result, DMZ Holding ApS has increased their ownership stake to over 5% in Pharma Equity Group A/S.

 

 

For further information, please contact:

 
  Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: +45 4022 2114

Christian Vinding Thomsen, Chairman of the Board of Directors of Pharma Equity Group A/S, phone: +45 2622 7222
   

About Pharma Equity Group A/S

Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthcare, Pharma Equity Group's primary objective is to bring significant value to Reponex Pharmaceuticals' medical projects.

The company is committed to providing extensive support, resources, and expertise to drive the development and success of these projects. As a strategic partner, Pharma Equity Group works closely with Reponex Pharmaceuticals, prioritizing the advancement of innovative medical solutions and breakthrough therapies. Every effort is currently directed towards ensuring the utmost success and impact of Reponex Pharmaceuticals' medical projects, with an unwavering dedication to improving global healthcare outcomes. Only when the full potential of Reponex Pharmaceuticals has been unfolded is the intention to explore opportunities to invest in other companies. This approach ensures a strong commitment to the current medical projects and their development, while - on the longer term - remaining open to new strategic investments for continuous growth.

 

 

Attachment

2024 04 23 - Announcement no. 14 - UK

\Hugin

Udgivet af: NPinvestordk

Mest læste lige nu

Danske Banks aktie presses ekstra af skuffelse over kommentarer om aktietilbagekøb
Ørsteds bestyrelsesformand købre aktier for knap en halv mio. kr.
Shipping: Baltic Dry-indekset falder 2,2 pct. til 534
Novos kassemester: Vi kan virkelig lide hvad vi ser for Wegovy i USA
Trump Medias revisor anklages for omfattende svindel af de amerikanske børsmyndigheder
 

Seneste nyheder

17:44 Europa/aktier: Rockwool endte i toppen af let stigende Stoxx 600
17:05 Trump Medias revisor anklages for omfattende svindel af de amerikanske børsmyndigheder
17:04 Fredagens aktier: Positiv ugeafslutning efter jobtal, regnskaber og Rockwool-opjustering
17:02 Fredagens obligationer: Rentefald tiltog i styrke efter jobtal fra USA
16:15 Rockwool i stærk start på 2024: Estimaterne skal op, mener Jyske
15:32 USA/åbning: Jobtal giver ekstra vitaminboost til amerikanske aktier fra børsstarten fredag
14:57 Økonomer om amerikanske jobtal: Opbremsning er et skridt i den rigtige retning
14:54 Valuta: Dollar svækkes efter opbremsning i jobskabelsen i USA
14:37 C25 går lodret op og renter ned efter svage jobtal fra USA
14:35 Amerikansk rapport viser lavere jobskabelse og lønstigninger end ventet
14:00 USA/aktier: Apple står til stor gevinst fra start - jobtal er dagens joker
13:49 Rockwool opjusterer forventningerne til 2024 efter stærkt kvartal
13:17 Pandoras bestyrelsesformand sælger aktier for knap 5,7 mio. kr.
13:04 Ørsteds bestyrelsesformand købre aktier for knap en halv mio. kr.
13:01 Novo Nordisk og Mærsk stopper samarbejde med Copenhagen Pride
12:48 Europa/aktier: Danske selskaber i top og bund i stigende Stoxx 600
12:22 Obligationer/middag: Renterne er trukket lidt ned før jobtal fra USA
11:49 Danske Banks aktie presses ekstra af skuffelse over kommentarer om aktietilbagekøb
11:48 Aktier/middag: Danske Bank og Novo trækker C25 i rødt
10:49 ALK's topchef om optimeringsplan: Skal sikre råderum til investeringer og bedre bundlinje